Newton Biocapital — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
Sequana Medicalsequanamedical.comin𝕏Oct 2018✓ verifiedDefunct
Sequana Medical develops the alfapump system and DSR therapy for treating fluid overload in patients with conditions such as liver disease and heart failure.
BiotechHealthtechMedical DevicesGhent, BE
Co-investorsKreos CapitalBlackRockEQT Life SciencesRosetta Capital Ltd.VI PartnersBootstrap Europe+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.



